Severe Liver Injury in Patients Taking the Asthma Medication Zafirlukast
Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.
Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician.
What is the problem and what is known about it so far?
Zafirlukast is a relatively new asthma medication. In initial studies, up to 5% of patients who took this drug had abnormal results on liver tests, but no symptomatic liver problems occurred.
Why did the researchers do this particular study?
To describe three patients who developed severe liver injury while taking …
This 100-word excerpt has been provided in the absence of an abstract.
Most Read
